Health
Public Health Wales apology over lack of clarity on smear test changes
PUBLIC HEALTH WALES has apologised and admitted it hasn’t “done enough” to explain the reasons for increasing the length of time between cervical screening tests.
The change, which was announced on Tuesday, means people aged between 25 and 50 with a cervix will now wait five years until another test, rather than three, providing no human papillomavirus (HPV) cells are detected.
HPV is a very common virus that most people will come into contact with at some time during their lives. One or more high-risk types of HPV are present in over 99.8% of cervical cancers.
HPV testing was successfully introduced in Wales in 2018 and almost nine out of 10 results show no high-risk HPV.
There are about 160 cases of cervical cancer diagnosed every year in Wales and it is the most common cancer in women under the age of 35.
But Public Health Wales has admitted it has failed to give clear information over the change, leading to concerns cancers could be missed.
In a tweet this weekend PHW said: “We are sorry. We haven’t done enough to explain the changes to cervical screening and have caused concern. We are working to make this clearer and more information will be available as soon as we can today and in the coming days.”
Cancer charities have sought to reassure women concerned by the change. Cancer Research UK has said people should be aware increasing the gap between screenings is “safe” and the new form of testing means people are invited for further based on their risk of developing cancer rather than their age.
An online petition, calling for the reintroduction of the three year gap between routine smear tests, has now attracted more than 680,000 signatures.
Alice Davies, Cancer Research UK’s health information manager, said people should be aware the decision to increase the time between screenings was made on scientific advice and due to a new way of testing samples which detects human papilloma virus (HPV) and means doctors are better able to identify those at risk of developing cervical cancer.
Ms Davies said: “As the new test is more accurate at finding those at risk of cervical cancer, screening intervals can be safely extended from three to five years.
“If someone is HPV positive then their next screening interval will be shorter than five years. The new test allows women to be invited back for screening based on their risk of developing cervical cancer, rather than just their age.
“Overall this makes the programme more accurate, and means people don’t have extra rounds of screening that wouldn’t give them any benefit, while offering more screening to people at higher risk.”
On Wednesday Public Health Wales said it accepted it has to do more to explain the reasons for the change.
Charity Jo’s Cervical Cancer Trust, described as the UK’s leading cervical cancer charity, has sought to reassure people concerned about the changes.
It has said the change has been introduced following advice from the UK National Screening Committee which recommended the five year gap between tests due to the use of HPV tests which are more sensitive and effective.
It said this means the advice is most women aged 25 to 49 can, as those aged 50 to 64 are, can be tested every five years rather than three.
The charity says the improved testing will likely mean more lives saved by identifying those at greater risk of cancer earlier.
According to Jo’s Cervical Cancer Trust women in Wales, and Scotland, are invited back based on the result of the screening.
If those show high-risk HPV and cell changes you will be invited to colposcopy.
If it identified high-risk HPV but no cell changes you will be invited for cervical screening in one year.
If there is no HPV you will be invited for cervical screening in five years.
Public Health Wales says HPV testing was introduced in Wales in 2018 and almost nine out of 10 results show no high-risk HPV.
Heather Lewis, consultant in public health for Cervical Screening Wales said: “The HPV test we now use in Wales is more effective at identifying people at higher risk of developing cell changes which can cause cervical cancer.
“The evidence shows that it is therefore safe to extend the time between cervical screening tests for people who do not have HPV identified.”
HPV is a very common virus that most people will come into contact with at some time during their lives. One or more high-risk types of HPV are present in over 99.8% of cervical cancers.
Increasing the time between smear tests will also reduce risks from screening.
Head of Programme for Cervical Screening Wales at Public Health Wales, Louise Dunk said: “Testing everyone who attends for cervical screening using a test for high risk HPV will identify those at risk and prevent more cancers than just examining the cells alone.
“It is a really positive development that this more effective test will mean that women and people with a cervix, who test negative for HPV, now only need to attend their testing every five years, rather than three.”
There are around 160 cases of cervical cancer diagnosed every year in Wales and it is the most common cancer in women under the age of 35.
Health
RCN Wales appoints Nicola Williams as Executive Director
NICOLA WILLIAMS will take up the role in April, bringing more than three decades of experience in nursing and senior leadership.
The Royal College of Nursing (RCN) has announced the appointment of Nicola Williams as its new Executive Director for Wales.
She joins the organisation from Velindre University NHS Trust, where she currently serves as Executive Director for Nursing, Allied Health Professionals and Health Care Scientists. With 38 years of experience in nursing and more than six years at executive board level, she is widely recognised across NHS Wales for her work in improving patient outcomes.
A highly experienced strategic leader, Williams has worked across a wide range of clinical and organisational settings. She has led major transformation programmes, strengthened national clinical leadership networks and championed innovation and evidence-based improvements in care. Her work has contributed to changes adopted across Wales and has been recognised with national awards.
Speaking about her appointment, Nicola Williams said: “I feel privileged to be appointed as Executive Director of RCN Wales. I’m a proud nurse, passionate about patient safety and improving care standards.
“Delivering the best care is only possible when nursing staff are supported to work in safe, inclusive environments. I will stand alongside members and their patients.
“Nursing staff are the backbone of health and care. I am determined to support our members across Wales, wherever they work, to meet the challenges ahead and shape the future of our profession.
“I look forward to meeting members across Wales and ensuring our work is informed by their experiences and expertise.”
In her new role, Williams will lead the RCN’s work in Wales and provide strategic leadership across key priority areas spanning the UK.
She succeeds Helen Whyley, who has held the position since February 2019 and will move into a new role as Director of Service Innovation at the RCN.
Health
Decision pending on adult mental health referral pathway
HYWEL DDA University Health Board will decide next week whether to make changes to the GP referral pathway for routine adult mental health services permanent.
The decision will be taken at a public Board meeting on Thursday (Mar 26).
Board members will consider a proposal to formalise changes already introduced in Ceredigion and, if approved, roll out the revised pathway across Pembrokeshire and Carmarthenshire.
Since March 2025, adults in Ceredigion seeking routine mental health support have been advised by their GP to contact the NHS 111 Wales ‘Press 2’ service, rather than being referred directly to the county’s Community Mental Health Team.
The temporary change was introduced in response to ongoing staffing shortages. Health Board officials say the approach has helped maintain timely access to face-to-face assessments for those who need them, while directing initial contact through a single access point.
The 111 ‘Press 2’ service provides telephone assessments by local wellbeing practitioners, supervised by registered mental health nurses, offering advice, support and onward referrals where required.
At its November 2025 meeting, the Board agreed to extend the temporary pathway until the end of March 2026. A nine-week engagement exercise followed, running from December 8 to February 9, to gather feedback from patients, professionals and stakeholders on the potential long-term impact.
Andrew Carruthers, Chief Operating Officer at Hywel Dda University Health Board, said: “I would like to thank everyone who took the time to share their views and experiences.
“I would also like to thank West Wales Action for Mental Health for supporting engagement with patients, including those with lived experience, alongside GPs, primary care teams, mental health staff and third sector partners.
“Our priority is to ensure mental health services remain accessible, fair and sustainable. The temporary changes in Ceredigion have shown some positive benefits, and the feedback we have received from across the three counties will play an important role in shaping the Board’s decision.”
The Board will review all evidence and feedback before making a final decision on the future of the adult mental health referral pathway.
GPs will continue to refer patients with urgent or complex needs directly to community mental health teams where appropriate, and have access to a dedicated NHS 111 professional line for additional clinical advice.
Further details, including the full Board papers, are available here:
https://biphdd.gig.cymru/amdanom-ni/eich-bwrdd-iechyd/cyfarfodydd-y-bwrdd-2026/agenda-a-phapuraur-bwrdd-26-mawrth-2026/
The meeting will be streamed live from 9:30am on Thursday (Mar 26) via:
www.youtube.com/hywelddahealthboard1
Health
Parents urged to check children’s vaccinations after meningitis cases
Local pharmacy reports MenB vaccine shortage amid rising concern
PARENTS and carers across west Wales are being urged to check their children’s vaccination status following recent meningitis cases in the UK.
The warning comes as a local pharmacy has confirmed a shortage of the Meningitis B (MenB) vaccine, highlighting growing pressure on supplies.
Mendus Pharmacy said it currently has no availability of the vaccine due to what it described as a nationwide supply issue.

In a statement, the pharmacy said: “We would like to inform our patients that, due to ongoing supply issues, we currently have no availability of the Meningitis B vaccine.
“Unfortunately, this is a nationwide shortage and all stock is currently unavailable.
“We understand this may be particularly concerning given the recent outbreak reported in Kent, and we completely appreciate the importance of timely vaccination.”
The pharmacy confirmed it is operating a waiting list and will contact patients once supplies return.
Health officials say keeping vaccinations up to date remains one of the most effective ways to prevent serious illness and reduce pressure on NHS services.
Dr Ardiana Gjini, Executive Director of Public Health at Hywel Dda University Health Board, urged parents to act.
She said: “Vaccination is one of the most effective ways we can protect children and young people from serious illness.
“Ensuring your child is fully vaccinated not only safeguards their health but also helps prevent the spread of infections within our communities.
“I strongly encourage all parents and carers to check their child’s vaccination status. If you are concerned that your child may have missed routine vaccinations, please speak to your GP.”
Meningococcal disease is a serious and potentially life-threatening infection that can lead to meningitis or septicaemia. While many people recover, some are left with long-term physical, neurological or psychological complications. Around one in ten cases can be fatal.
Although the disease can affect anyone, babies, young children, teenagers and young adults are at greatest risk.
In Wales, vaccines protecting against meningococcal strains A, B, C, W and Y are offered as part of the NHS immunisation programme. Infants receive the MenB vaccine, while teenagers are offered the MenACWY vaccine.
Latest figures from the Health Board show that uptake among 16-year-olds for the MenACWY vaccine stands at 76.4%, meaning a significant number of young people remain unprotected as they approach adulthood.
For younger children, uptake of the MenB vaccine is higher but still below the recommended 95% target. Around 92.8% of infants are vaccinated by their first birthday, rising slightly to 91.8% by their second.
Health officials say these figures reflect strong engagement from families and primary care teams but stress that continued vigilance is needed.
Families are being advised to check their child’s vaccination record with their GP or by contacting the Health Board directly. Parents should also ensure babies receive their scheduled MenB doses and that teenagers receive their MenACWY and 3-in-1 booster vaccines, which are currently being delivered in schools.
Parents are also urged to remain alert to the symptoms of meningitis and septicaemia and to seek urgent medical advice if they have concerns.
Further information on symptoms is available via NHS 111 Wales.
-
News5 days agoEmergency services flood Haverfordwest after reports of person in river
-
Crime4 days agoMother given community order after admitting child cruelty offence
-
Crime7 days agoMan cleared of sexual assault allegation after magistrates rule no case to answer
-
Health3 days agoNHS waiting list falls — but cancer delays and diagnostic backlog worsen
-
News5 days agoSenedd vote to ban greyhound racing hailed as ‘landmark moment’ by charities
-
News5 days agoSenedd votes to ban Greyhound racing in Wales to protect animal welfare
-
News4 days agoReform secures first Pembrokeshire councillor in Hakin by-election win
-
Sport7 days agoFrance crowned Six Nations champions after extraordinary final-day drama










